Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-Valent Pneumococcal Conjugate Vaccine - Related Studies

Home

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-Valent Pneumococcal Conjugate Vaccine

This study has been completed.

Study NCT00345358. Last updated on October 9, 2008. Information provided by GlaxoSmithKline

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pneumococcal Disease

2	Interventions listed in this trial
		Infanrix IPV/Hib

3	Sponsors listed in this trial
		GlaxoSmithKline